Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Distilling the news: one month into the FT Edit App

A tablet with seven abstract content panels on its screen sits on a desk against a softly shaded globe backdrop.

Distilling the news: one month into the FT Edit App presents seven takeaways from our global journalism seminar with Malcolm Moore, editor of this innovative news product launched by the FT in March 2022. This Professional Development event takes place on Zoom on April 27, 2022.

Hosted with: Psychedelic Writers Guild